Exact Mass: 463.1577118000001
Exact Mass Matches: 463.1577118000001
Found 102 metabolites which its exact mass value is equals to given mass value 463.1577118000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rosuvastatin 5 S-lactone
C22H26FN3O5S (463.1577118000001)
Rosuvastatin 5 S-lactone is a metabolite of rosuvastatin. Rosuvastatin (marketed by AstraZeneca as Crestor) is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It was developed by Shionogi. (Wikipedia)
ent-Rosuvastatin Lactone
C22H26FN3O5S (463.1577118000001)
Sipoglitazar
C25H25N3O4S (463.15656900000005)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
(S)-Phenyl-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-acetonitril|(S)-phenyl-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-acetonitrile|sambunigrin tetraacetate
Thr Asp Asn Asp
C16H25N5O11 (463.15504999999996)
Cys Met Asn Pro
Cys Met Pro Asn
Cys Asn Met Pro
Cys Asn Asn Asn
Cys Asn Pro Met
Cys Pro Met Asn
Cys Pro Asn Met
Asp Asp Asn Thr
C16H25N5O11 (463.15504999999996)
Asp Asp Gln Ser
C16H25N5O11 (463.15504999999996)
Asp Asp Ser Gln
C16H25N5O11 (463.15504999999996)
Asp Asp Thr Asn
C16H25N5O11 (463.15504999999996)
Asp Glu Asn Ser
C16H25N5O11 (463.15504999999996)
Asp Glu Ser Asn
C16H25N5O11 (463.15504999999996)
Asp Asn Asp Thr
C16H25N5O11 (463.15504999999996)
Asp Asn Glu Ser
C16H25N5O11 (463.15504999999996)
Asp Asn Ser Glu
C16H25N5O11 (463.15504999999996)
Asp Asn Thr Asp
C16H25N5O11 (463.15504999999996)
Asp Gln Asp Ser
C16H25N5O11 (463.15504999999996)
Asp Gln Ser Asp
C16H25N5O11 (463.15504999999996)
Asp Ser Asp Gln
C16H25N5O11 (463.15504999999996)
Asp Ser Glu Asn
C16H25N5O11 (463.15504999999996)
Asp Ser Asn Glu
C16H25N5O11 (463.15504999999996)
Asp Ser Gln Asp
C16H25N5O11 (463.15504999999996)
Asp Thr Asp Asn
C16H25N5O11 (463.15504999999996)
Asp Thr Asn Asp
C16H25N5O11 (463.15504999999996)
Glu Asp Asn Ser
C16H25N5O11 (463.15504999999996)
Glu Asp Ser Asn
C16H25N5O11 (463.15504999999996)
Glu Asn Asp Ser
C16H25N5O11 (463.15504999999996)
Glu Asn Ser Asp
C16H25N5O11 (463.15504999999996)
Glu Ser Asp Asn
C16H25N5O11 (463.15504999999996)
Glu Ser Asn Asp
C16H25N5O11 (463.15504999999996)
Met Cys Asn Pro
Met Cys Pro Asn
Met Asn Cys Pro
Met Asn Pro Cys
Met Pro Cys Asn
Met Pro Asn Cys
Asn Cys Met Pro
Asn Cys Asn Asn
Asn Cys Pro Met
Asn Asp Asp Thr
C16H25N5O11 (463.15504999999996)
Asn Asp Glu Ser
C16H25N5O11 (463.15504999999996)
Asn Asp Ser Glu
C16H25N5O11 (463.15504999999996)
Asn Asp Thr Asp
C16H25N5O11 (463.15504999999996)
Asn Glu Asp Ser
C16H25N5O11 (463.15504999999996)
Asn Glu Ser Asp
C16H25N5O11 (463.15504999999996)
Asn Met Cys Pro
Asn Met Pro Cys
Asn Asn Cys Asn
Asn Asn Asn Cys
Asn Pro Cys Met
Asn Pro Met Cys
Asn Ser Asp Glu
C16H25N5O11 (463.15504999999996)
Asn Ser Glu Asp
C16H25N5O11 (463.15504999999996)
Asn Thr Asp Asp
C16H25N5O11 (463.15504999999996)
Pro Cys Met Asn
Pro Cys Asn Met
Pro Met Cys Asn
Pro Met Asn Cys
Pro Asn Cys Met
Pro Asn Met Cys
Gln Asp Asp Ser
C16H25N5O11 (463.15504999999996)
Gln Asp Ser Asp
C16H25N5O11 (463.15504999999996)
Gln Ser Asp Asp
C16H25N5O11 (463.15504999999996)
Ser Asp Asp Gln
C16H25N5O11 (463.15504999999996)
Ser Asp Glu Asn
C16H25N5O11 (463.15504999999996)
Ser Asp Asn Glu
C16H25N5O11 (463.15504999999996)
Ser Asp Gln Asp
C16H25N5O11 (463.15504999999996)
Ser Glu Asp Asn
C16H25N5O11 (463.15504999999996)
Ser Glu Asn Asp
C16H25N5O11 (463.15504999999996)
Ser Asn Asp Glu
C16H25N5O11 (463.15504999999996)
Ser Asn Glu Asp
C16H25N5O11 (463.15504999999996)
Ser Gln Asp Asp
C16H25N5O11 (463.15504999999996)
Thr Asp Asp Asn
C16H25N5O11 (463.15504999999996)
Thr Asn Asp Asp
C16H25N5O11 (463.15504999999996)
4-[(5-Amino-1-methyl-1H-indol-3-yl)methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide
C25H25N3O4S (463.15656900000005)
His-Trp-OH
C23H21N5O6 (463.14917660000003)
Trp-His-OH
C23H21N5O6 (463.14917660000003)
1-((4-CHLOROPHENYL)SULFONYL)-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE
C21H27BClN3O4S (463.1503762000001)
2-ethoxyethyl [2-[(2-chloro-4-nitrophenyl)azo]-5-(diethylamino)phenyl]carbamate
C21H26ClN5O5 (463.1622376000001)
Native Streptomyces griseus Aminopeptidase I
C17H25N7O4.2[HCl] (463.1501482)
Pelitrexol
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2692 - Glycinamide Ribonucleotide Formyltransferase Inhibitor
1-[2-[[[2-Chloro-4-(trifluoromethyl)anilino]-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester
C20H25ClF3N3O4 (463.14855960000006)
3-[2-[1-(4-methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]spiro[6,7-dihydro-5H-1-benzothiophene-4,5-imidazolidine]-2,4-dione
C25H25N3O4S (463.15656900000005)
N-(3-chloro-4-fluorophenyl)-6-[3-(4-hydroxymorpholin-4-ium-4-yl)propoxy]-7-methoxyquinazolin-4-amine
ERK1/2 inhibitor 7
ERK1/2 inhibitor 7 is a potent ERK inhibitor with an IC50 of 0.94 nM for ERK2 (WO2021110168A1, WX006)[1].
MGL-IN-1
MGL-IN-1 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor. MGL-IN-1 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. MGL-IN-1 displays high membrane permeability and brain penetrant[1].